Drug Type Small molecule drug |
Synonyms Bisoprolol Fumarate and Hydrochlorothiazide, ZIAC |
Target |
Action inhibitors, antagonists |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (26 Mar 1993), |
Regulation- |
Molecular FormulaC22H35NO8 |
InChIKeyRZPZLFIUFMNCLY-WLHGVMLRSA-N |
CAS Registry104344-23-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 26 Mar 1993 |
Not Applicable | - | 5 | fajwheliog(kqidgksurh) = reduced risk of any AE and peripheral edema compared to control lclsjobpbc (wqjlizzqyp ) View more | Positive | 01 Jun 2023 | ||
(Control) |